Aim of the study. To assess the influence of age on long-term functional outcome in patients with acute ischaemic stroke (AIS) treated with intravenous thrombolysis (IVT).Material and methods. We performed retrospective analysis of 362 AIS patients treated with IVT or IVT and subsequent mechanical thrombectomy in the University Hospital in Krakow, Poland. Patients were categorised into four subgroups by age: (I) below the age of 60, (II) 60 to 69, (III) 70 to 79, and (IV) 80 or more. The outcomes were assessed with modified Rankin scale (mRS) 90 days after stroke onset, and defined as favourable (mRS 0–2), poor (mRS 3–5), or death (mRS = 6).Results. Patients aged 80 or more compared to those below 60 were more often women (72.64% vs. 26.76%...
BACKGROUND The probability to receive intravenous thrombolysis (IVT) for treatment of acute ische...
Background: In recent randomized controlled trials (RCTs) intra-arterial treatment (IAT) has been pr...
BACKGROUND: The benefit of intravenous tissue plasminogen activator (tPA) given within 3 h of acute ...
Objectives: This retrospective single-center study aimed to investigate the risk factors, outcomes a...
Background: In recent randomized controlled trials (RCTs) intra-arterial treatment (IAT) has been pr...
<p><b>Background and Purpose:</b> Thrombolysis for acute ischemic stroke in patien...
The probability to receive intravenous thrombolysis (IVT) for treatment of acute ischemic stroke dec...
Objective To assess effect of age on response to alteplase in acute ischaemic stroke. Design Adju...
Background and Purpose-Demographic changes will result in a rapid increase of patients age >= 90 ...
BACKGROUND: Despite stroke's high prevalence in the elderly, intravenous thrombolysis is licensed i...
BACKGROUND: Despite stroke's high prevalence in the elderly, intravenous thrombolysis is licensed i...
Background Stroke is among the most common causes of death and disability worldwide. Despite the re...
Intravenous thrombolysis with alteplase within 4.5 hours from symptom onset is a well-established tr...
SummaryBackgroundThrombolysis is of net benefit in patients with acute ischaemic stroke, who are you...
Introduction: Stroke in young people has a major socioeconomic impact, since up to 30% of young pati...
BACKGROUND The probability to receive intravenous thrombolysis (IVT) for treatment of acute ische...
Background: In recent randomized controlled trials (RCTs) intra-arterial treatment (IAT) has been pr...
BACKGROUND: The benefit of intravenous tissue plasminogen activator (tPA) given within 3 h of acute ...
Objectives: This retrospective single-center study aimed to investigate the risk factors, outcomes a...
Background: In recent randomized controlled trials (RCTs) intra-arterial treatment (IAT) has been pr...
<p><b>Background and Purpose:</b> Thrombolysis for acute ischemic stroke in patien...
The probability to receive intravenous thrombolysis (IVT) for treatment of acute ischemic stroke dec...
Objective To assess effect of age on response to alteplase in acute ischaemic stroke. Design Adju...
Background and Purpose-Demographic changes will result in a rapid increase of patients age >= 90 ...
BACKGROUND: Despite stroke's high prevalence in the elderly, intravenous thrombolysis is licensed i...
BACKGROUND: Despite stroke's high prevalence in the elderly, intravenous thrombolysis is licensed i...
Background Stroke is among the most common causes of death and disability worldwide. Despite the re...
Intravenous thrombolysis with alteplase within 4.5 hours from symptom onset is a well-established tr...
SummaryBackgroundThrombolysis is of net benefit in patients with acute ischaemic stroke, who are you...
Introduction: Stroke in young people has a major socioeconomic impact, since up to 30% of young pati...
BACKGROUND The probability to receive intravenous thrombolysis (IVT) for treatment of acute ische...
Background: In recent randomized controlled trials (RCTs) intra-arterial treatment (IAT) has been pr...
BACKGROUND: The benefit of intravenous tissue plasminogen activator (tPA) given within 3 h of acute ...